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ABSTRACT In vivo transcriptional analyses of microbial pathogens are often hampered by low proportions of pathogen biomass
in host organs, hindering the coverage of full pathogen transcriptome.We aimed to address the transcriptome profiles of Can-
dida albicans, the most prevalent fungal pathogen in systemically infected immunocompromised patients, during systemic in-
fection in different hosts. We developed a strategy for high-resolution quantitative analysis of the C. albicans transcriptome di-
rectly from early and late stages of systemic infection in two different host models, mouse and the insect Galleria mellonella. Our
results show that transcriptome sequencing (RNA-seq) libraries were enriched for fungal transcripts up to 1,600-fold using bio-
tinylated bait probes to capture C. albicans sequences. This enrichment biased the read counts of only ~3% of the genes, which
can be identified and removed based on a priori criteria. This allowed an unprecedented resolution of C. albicans transcriptome
in vivo, with detection of over 86% of its genes. The transcriptional response of the fungus was surprisingly similar during infec-
tion of the two hosts and at the two time points, although some host- and time point-specific genes could be identified. Genes
that were highly induced during infection were involved, for instance, in stress response, adhesion, iron acquisition, and biofilm
formation. Of the in vivo-regulated genes, 10% are still of unknown function, and their future study will be of great interest. The
fungal RNA enrichment procedure used here will help a better characterization of the C. albicans response in infected hosts and
may be applied to other microbial pathogens.
IMPORTANCE Understanding the mechanisms utilized by pathogens to infect and cause disease in their hosts is crucial for ratio-
nal drug development. Transcriptomic studies may help investigations of these mechanisms by determining which genes are
expressed specifically during infection. This task has been difficult so far, since the proportion of microbial biomass in infected
tissues is often extremely low, thus limiting the depth of sequencing and comprehensive transcriptome analysis. Here, we
adapted a technology to capture and enrich C. albicans RNA, which was next used for deep RNA sequencing directly from in-
fected tissues from two different host organisms. The high-resolution transcriptome revealed a large number of genes that were
so far unknown to participate in infection, which will likely constitute a focus of study in the future. More importantly, this
methodmay be adapted to perform transcript profiling of any other microbes during host infection or colonization.
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Candida albicans is the most prevalent fungal pathogen. It isable to live and proliferate in a wide range of human body
sites, including skin and mucosa, but also in the bloodstream and
virtually all internal organs. Systemic infections in immunocom-
promised patients result in mortality rates of around 50% (1, 2).
Therefore, available antifungal therapies need to be comple-
mented by new drugs, preferentially directed against new targets
to avoid cross-resistance. To identify potential novel targets in
C. albicans, a deep understanding of the host-microbe interactions
is needed. In particular, the mechanisms that allow adaptation of
the pathogen to the different environments in the infected host are
of great interest.
Transcriptional regulation is crucial for these adaptive pro-
cesses, and thus transcriptomic studies during the course of infec-
tion, or under conditions that mimic this process, can provide
valuable insights. Previous studies attempted to characterize the
transcriptional response of C. albicans during the infection pro-
cess. Most of these studies were performed in vitro, under condi-
tions that mimic some of the stresses encountered by the fungus
within its host (3–14), or using mammalian cells (15–18) and
tissue cultures (19–21). Recent studies suggest that regulatory cir-
cuits take different trajectories in vitro and in vivo (22–24). For
example, a recent study showed that the transcriptional profile of
C. albicans transcription factor mutants (for example, RIM101,
EFG1, andZAP1mutants) are dramatically different during infec-
tion and during growth in vitro (24). These findings further em-
phasize the importance of performing transcriptional analysis di-
rectly during infection. Some transcriptional studies have been
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performed on mouse kidneys systemically infected with C. albi-
cans (25), on liver (26), on biofilms grown on devices placed in the
bloodstream (27), or on feces of gastrointestinally infected mice
(28). However, all these attempts have turned out to be a great
challenge for investigators, since fungal RNA levels in recovered
infected organs were very low compared to host RNA. Until now,
different strategies were developed to overcome this problem, in-
cluding isolation of fungal cells prior to RNA extraction (25), or
specific fungal RNA amplification post-RNA extraction (26). In
the first case, cells were necessarily exposed to environmental
changes due to the enrichment procedure before transcription
and RNA degradation could be mitigated, thus modifying the ob-
served transcriptional response (25). In the second case, the RNA
population was biased due to a nonlinear amplification of fungal
RNA because of the presence of large amounts of host RNA (26).
Alternative animal models have also been used, such as the rabbit
(29) or the zebrafish (30), in order to recover higher fungal bio-
mass and to be able to perform direct transcript profiling analyses
on fungal RNA. Most of the studies mentioned so far used mi-
croarrays to analyzeC. albicans transcription regulation, a method
with relatively low sensitivity in quantifying the absolute expres-
sion values and in the detection of low abundance genes (31). A
different technology (NanoString) was recently adapted to C. al-
bicans and allows fungal transcription profiling on samples con-
taining less than 0.1% C. albicans RNA (22). Even though Nano-
String overcomes the problem of low fungus/host RNA ratio and
has a high multiplex capability, it is still limited to a restricted
number of target genes and thus cannot yield a comprehensive
transcriptional profile (32).
A powerful technology consisting of direct RNA sequencing
(RNA-seq) has increased detection sensitivity and is capable of
absolute quantification of gene expression (33). It has lately been
used to study genome-wide C. albicans transcriptional profiles in
vitro (34–36) or in C. albicans-infected mammalian cells (37, 38).
So far, to our knowledge, only two studies have attempted the
analysis of theC. albicans transcriptome by RNA-seq directly from
host infections (38, 39). However, these studies were also con-
fronted with the recurrent problem of the low fungal transcript
proportion in the total RNA extracted, resulting in extremely low
percentages of fungal transcripts. Such samples do not permit an
acceptable sequencing depth, resulting in the detection of a small
number of highly expressed genes only.
Here, we developed a strategy to extract RNA from infected
hosts at early and late stages of infection and to enrich the total
RNA extract inC. albicansmRNA, using an mRNA capture-based
technology. This technology was initially developed to analyze the
human exome or a small targeted panel of genes by RNA-seq
approaches. In this study, we adapted this tool to C. albicans. For
these analyses, we chose two different hosts, the mouse model of
systemic infection, which is the animal model most commonly
used to study C. albicans virulence, and the larvae of Galleria mel-
lonella. This insect model is increasingly used as an alternative to
mammals. Several studies showed good correlations between the
results obtained with this model and the gold standard mouse
model when C. albicans virulence factors were investigated (re-
viewed in reference 40). First, we demonstrate here that our se-
lected RNA enrichment method does not introduce a bias for
~97% of the genes in the relative C. albicans RNA population
when enriched and nonenriched samples were compared. Second,
our results highlight the idea that an unprecedented resolution of
the C. albicans transcriptome can be achieved under in vivo con-
ditions, since we were able to attribute RNA-seq reads to over
6,000 C. albicans genes. Among these, we found a core of about
1,200 genes that are commonly regulated in the two infection
models at early and late stages of infection, relative to in vitro
grown cells. Among the in vivo-regulated genes, we confirmed the
involvement of genes previously known to participate in infec-
tion, but we also found a large group of genes with yet-
uncharacterized functions which constitute interesting future av-
enues of investigation.
RESULTS
Development of the RNA enrichment method to analyze the
transcriptional profile of a microorganism within its host. (i)
Adaptationof the SureSelectmethod toC. albicans.After extrac-
tion of total RNA from C. albicans infected mouse kidneys or
G. mellonella (see Fig. S1 in the supplemental material), we esti-
mated the percentage of C. albicans RNA in samples. Infecting
animals with 5  105 C. albicans cells resulted in RNA samples
with a range of 0.1 to 1% pathogen RNA at early time points
(mouse kidneys, 16 h postinfection [p.i.]; G. mellonella, 2 h p.i.).
Because the amounts of pathogen RNA in our samples were so
small, standard RNA-seq was not feasible, since it would result in
low transcriptome coverage and prevent the analysis of genes ex-
pressed at low levels. Therefore, an approach for fungal RNA en-
richment based on the SureSelect capture system (Agilent Tech-
nologies) was applied. This system uses biotinylated probes that
we designed to specifically match the C. albicans ORFome (see
Materials and Methods). When this system was applied, the per-
centages of reads aligned to the pathogen of a given in vivo sample
were increased up to 1,670-fold (Table 1; also, see Table S1 in the
supplemental material). However, even if this technology was ear-
lier applied and validated for human exome sequencing, it was still
necessary to verify that the enrichment process did not bias the
results, i.e., that the relative C. albicans RNA population in en-
riched samples remained the same as in the original samples.
(ii) Validation of C. albicans RNA enrichment. Our aims
were to (i) establish for which C. albicans genes the SureSelect
protocol yielded quantitatively reliable counts, (ii) rationally dis-
card outlier genes (those unlikely to produce reliable counts), and
TABLE 1 Enrichment of C. albicans RNA using the SureSelect procedure
Galleria, 2 h p.i. (G6) Galleria, 24 h p.i. (G12) Mouse, 16 h p.i. (K23) Mouse, 48 h p.i. (K29)
Method Nonenriched Enriched Nonenriched Enriched Nonenriched Enriched Nonenriched Enriched
Total reads 189Ma 24M 172M 191M 183M 38M 169M 31M
No. aligned to C. albicans 66Ka 14M 93K 121M 72K 15M 169K 21M
% aligned reads 0.03 58 0.05 63 0.04 39 0.1 69
Fold enrichment 1670 1172 1003 677
a M, million; K, thousand.
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(iii) issue recommendations for optimizing the bait probe design.
For this purpose, we investigated the correlation between the read
counts obtained from the sequencing of an RNA sample from in
vitro grown C. albicans cells, without enrichment, and the read
counts obtained using the SureSelect enrichment protocol from a
sample of host RNA spiked with 1% of the same C. albicans RNA
(samples designated with “C”). We performed two replicate ex-
periments using G. mellonella (samples designated with “G”) as
the host RNA (C5 versus G-C5; C6 versus G-C6) and two other
experiments using mouse kidney RNA (samples designated with
“K”) as the host RNA (C5 versus K-C5; C11 versus K-C11). These
samples are referred to here as nonenriched (C5, C6, and C11) and
enriched (G-C5, K-C5, G-C6, and K-C11) samples. The experi-
mental read counts are plotted in Fig. 1 and in Fig. S2 in the
supplemental material.
We exploited a machine learning approach to identify a com-
FIG 1 Correlation between enriched and nonenriched mRNA read counts ofC. albicans genes. The enriched reads were recovered from a sample of host mRNA
spiked with 1% of the same C. albicans mRNA. Scatter plots of log2 normalized RNA-seq counts and scatter plots of log2 fold change (log2FC) are shown. Green
indicates valid genes and red indicates genes rejected via our classification with selected features. ra, Pearson correlation for all genes; rv, Pearson correlation for
valid genes.
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bination of gene features that can be used to determine which
genes are suitable for the enrichment protocol. This combination
must be made of a priori criteria, like the sequence and the location
of the bait probes, and not of the experimental observation of gene
expression. We considered five different properties that can be
computed on the probes and that are likely to affect in some way
the nucleic acid hybridization on which the SureSelect protocol
relies. These properties are the following: (i) number of probes per
gene; (ii) GC content (percent) of the probes, (iii) presence of
low-complexity regions, (iv) RNA-folding energy, and (v) pres-
ence of highly similar probe sequences between different genes
(redundancy). One hundred fifty-eight binary features were com-
puted for these properties by introducing numerical thresholds,
for example a required minimal GC content, and by taking the
minimum, maximum, or average values over the probes that
cover every single gene. Table 2 summarizes the definitions of
these 158 binary features.
To select a subset of discriminative and nonredundant fea-
tures, we conducted a machine learning-based feature selection
process on an initial approximate classification of the genes. The
genes with4-fold changes between spiked enriched and nonen-
riched samples in all four experiments (5,615 genes) were tagged
as valid; those with4-fold changes in all four experiments were
tagged as rejected (144 genes); the remaining 124 unclassified
genes were left out of this selection step (see Fig. S2 in the supple-
mental material). Table 3 shows the different optimal subsets of
features returned by the five different algorithms investigated. As
each feature selection technique has its own advantages and dis-
advantages (41), we eventually retained the consensus of the fea-
tures obtained from these five methods, expressed as follows:
number of probes of1, average GC content of5%, and max-
imum GC content of 25%. That is, the valid genes must be
covered by more than one bait probe, on average the probe GC
content must be greater than 5%, and there should be at least one
probe with a GC content greater than 25% (C. albicans average GC
content is 33.5% [42]). Interestingly, the low complexity and re-
dundancy features were never selected, possibly because the probe
design protocol form SureSelect (possibly) already includes such
filters.
We then trained a support vector machine (SVM) (43) model
on the 5,615 valid and 144 rejected genes with the three selected
features. The obtained model showed that the three features had
equivalent importance in the SVM classifier. Table 4 shows all
combinations of the features and their frequency of occurrence for
the C. albicans genes and for the particular set of bait probes in-
vestigated here. Figure 1 shows the corresponding final classifica-
tion of the genes. The correlations of the gene counts (Fig. 1) were
improved from 0.93-0.94 to 0.98 by rejecting 662 genes out of
6,468 (according to SC5314 genome version A21-s02-m09-r07).
The standard deviations of log2 fold change were reduced from
0.72-0.76 to 0.44-0.47. Figure 1 also shows the correlations of the
log2 fold change between the initial nonenriched and the enriched
samples. The rejected genes (see File S1, “Gene_Filter_
Accepted_Rejected” in the supplemental material) clearly appear
as outliers in these two comparisons, which indirectly confirms
the effectiveness of our gene selection procedure.
Out of the 662 rejected genes, 411 were open reading frames
(ORFs), of which only 287 are expressed (see File S1, “Rejected_
genes_expressed” in the supplemental material). These corre-
sponded mostly to genes with mitochondrial functions or ribo-
somal genes (see File S1, “GO_term_rejected_expressed”). In
addition, baits were designed and constructed for only 8 of these
ORFs, the remaining being smaller than our size threshold of
370 bp (the first 250 bp of each gene not included in the design
plus 120 bp for the first bait). Taken together, the results of this
analysis show that the capture process was efficient and that the
excluded genes were unlikely to significantly affect the biological
interpretations drawn from these data.
Analysis of C. albicans transcriptome during infection fol-
lowing enrichment procedure. After validating the enrichment
method, we proceeded to the analysis ofC. albicans transcriptome.
For this analysis, samples from two infected hosts were compared
at two different time points to an in vitro reference spiked with
noninfected host material. All of these samples were subjected to
the same enrichment procedure (see Fig. S1 and Table S2 in the
supplemental material).
Normalized and Voom-transformed gene counts (see Materi-
als and Methods) from enriched RNA-seq samples were subjected
to hierarchical clustering and principal component analysis
(PCA) (Fig. 2; also, see File S1, “voom_normalized_gene_expres-
sion” in the supplemental material). As shown in Fig. 2a, samples
clustered according to their origin either from mouse, G. mello-
nella, or in vitro samples. The in vivo samples tended to cluster
together, distinct from in vitro samples. Biological replicates fell
into closely related groups. This is also visible in the PCA (Fig. 2b).
Taken together, these results suggest that the data produced were
of high quality, even after separate enrichment procedures.
Next, a linear model was built using the five different condi-
tions, in vitro plus early and late time points from mouse kidneys
TABLE 2 Binary featuresa
Property Threshold values No. of features
No. of probes per gene 1, 2, 3, 4, 5 5
% GCb 5, 10, 15, . . ., 95 57
% low-complexity sequenceb 5, 10, 15, . . ., 95 57
RNA-folding energyb 40,35,30, . . .,5 24
Redundancyb 1, 2, 3, 4, 5 15
a The 158 binary features associated with every gene and that can be computed from the
bait probe sequences and locations.
b Minimum, maximum, or average per gene.
TABLE 3 Feature combinations selected by the different feature selection methods
Method Selected features
Best first #probe 1, #probe 3, avg(%GC) 5, avg(%GC) 10, max(%GC) 25, min(%GC) 10
Greedy stepwise #probe 1, avg(%GC) 5, max(%GC) 25
Linear forward selection #probe 1, #probe 3, avg(%GC) 5, avg(%GC) 15, max(%GC) 25, min(%GC) 10
Scatter search #probe 1, avg(%GC) 5, max(%GC) 25
Subset size forward selection #probe 1, avg(%GC) 5, max(%GC) 25
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(16 h and 48 h) and G. mellonella (2 h and 24 h), as factors to
identify C. albicans transcriptome relationships between the dif-
ferent host models and time points. Differential expression of
C. albicans genes upon host and time of infection was calculated
relative to in vitro growth conditions (see File S1, “FC_
mouse_16h”, “FC_mouse_48h”, “FC_Galleria_2h”, and “FC_
Galleria_24h” in the supplemental material). The resulting fold
changes in gene expression were compared between hosts and
time points in a pairwise manner (Fig. 3). As expected, the best
correlation coefficients were obtained within the same host
(Fig. 3a and b) (r 0.752 between G. mellonella at 2 and 24 h; r
0.724 between mouse kidneys at 16 and 48 h). Interhost compar-
isons resulted in lower correlation coefficients; however, the
coefficient exhibited higher values when transcriptomes were
compared at late time points (Fig. 3c and d) (r  0.707 between
G.mellonella at 24 h and mouse kidneys at 48 h; r 0.611 between
G. mellonella at 2 h and mouse kidneys at 16 h). Even if the C. al-
bicans transcriptomes were derived from two distant hosts with
expected differences in response patterns, the correlations ob-
tained highlighted common transcriptomic responses for C. albi-
cans in the two infection models.
After processing of the RNA-seq data, we first evaluated differ-
ential expression of the C. albicans genes during infection com-
pared to in vitro growth conditions. Table 5 gives an overview of
the 20 most upregulated genes in G. mellonella and mice at differ-
ent time points, compared to in vitro conditions. The most up-
regulated genes at any time point included genes known to be
important for cell host adhesion, invasion, and dissemination,
including genes for a number of GPI-anchored proteins, such as
HWP1, RBT5, SOD5, ALS3, and the hypha-specific gene ECE1
(reviewed in reference 44). Two other genes involved in the regu-
lation of hyphal morphogenesis were present (HGC1 and UME6)
(45, 46). Finally, genes relevant to iron acquisition were also ob-
served (CFL2 and CFL5) (47). These data demonstrated that the
RNA-seq enrichment approach yielded data consistent with pub-
lished studies on genes involved in pathogenesis of C. albicans. In
addition, it demonstrated that some of the most important varia-
tions in gene expression occurred, unexpectedly, in the same way
in two distant hosts, mice and G. mellonella.
As an additional independent verification, we validated the RNA-
seq results by analyzing the expression levels of a selection of genes by
qPCR on cDNA obtained directly from the original RNA samples, in
which no RNA enrichment was carried out. These included genes up-
or downregulated in both mouse and G. mellonella and genes in-
versely regulated between the two animal models (see Fig. S3a in the
supplemental material). Fold change expression in in vivo samples
compared to in vitro inocula were highly concordant between the two
techniques (Spearman’s correlation [r]  0.92; P  0.0001) (see
Fig. S3b in the supplemental material).
TABLE 4 Gene classification based on the three selected featuresa
No. of
genes
No. of
probes 1
Avg %
GC 5
Max %
GC 25 Class
5806 1 1 1 Valid
8 1 1 0 Rejected
289 0 1 1 Rejected
18 0 1 0 Rejected
347 0 0 0 Rejected
a No gene had the combination 101, 100, or 001 (impossible combination), which
would have been classed as “acceptable.”
FIG 2 Hierarchical clustering (a) and principal component analysis (b) of in vivo and in vitro samples used to characterize C. albicans responses in the two host
models. Clustering and PCA were performed using Voom-transformed and normalized gene counts. The 5,365C. albicans genes with at least 1 count per million
in at least one sample were used for clustering and PCA. Additionally, clustering was also performed on the 1,000 genes with the highest variance across all 10
samples. Genes that did not meet the enrichment quality criteria were excluded. Gm, G. mellonella; Mm, Mus musculus.
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(i) Time-dependent genes in infectionmodels. As mentioned
above, the 2h and 16h time points in G. mellonella and mouse
experiments were considered early time points, while the 24h and
48h time points in both hosts were taken as late time points. When
comparing the results obtained at two time points (Fig. 3a and b),
we observed that the majority of genes remained in the same cat-
egory at both time points, either up- or downregulated compared
to the in vitro condition. Nevertheless, when a cutoff of a 2-fold
change between the two time points was applied, some early-
upregulated genes saw a further increase of their expression at late
time points, while for others, the upregulation was less pro-
nounced at the later time point (Fig. 3a and b, colored data
points). The same was valid for downregulated genes. Large dif-
ferences (more than 5.5-fold between time points) were observed
for several of these genes. For example, CFL5, encoding a ferric
reductase induced under low-iron conditions, was 5.3-fold more
expressed at the late time point than at the early time point in
mice, while this difference was 50-fold in G. mellonella. Other
genes participating to iron homeostasis and hemoglobin utiliza-
tion, including SIT1, FTR1, and RBT5 (48) were 6- to 7-fold more
expressed at late time points in G. mellonella than at early time
points. The same genes followed similar trends in mice; however,
they were only 2.5- to 7-fold more expressed at the late time point.
These data suggest that C. albicans needs to increase its iron cap-
ture capacity during the course of infection. Other genes, such as
ICL1, a gene which encodes isocitrate lyase and which is critical for
the glyoxylate cycle, were 11- and 9-fold more expressed at late
time points than early time points in both infection models, thus
revealing increased adaptation to alternative carbon sources in
C. albicans during these infection phases (49). The gene encoding
orf19.3499, a secreted protein that is Hap43 repressed, is upregu-
lated in both G. mellonella and mice at early time points (50- to
200-fold compared to expression in vitro). However, it is further
upregulated 1,000- to 2,000-fold in both hosts at later time points
as compared to in vitro. ALS3, which is important for adhesion to
host cells (50), was 250-fold upregulated at early time point but
FIG 3 Correlations between log2 fold changes (logFC). For each in vivo condition, its log fold change versus the in vitro condition was computed. (a and b) Early
versus late responses inG.mellonella and mouse. Brown dots indicate significant genes (false discovery rate [FDR] 5%) with a difference between early and late
fold changes larger than 2 (see Materials and Methods for statistical analysis). (c and d)G.mellonella versus mouse responses for early and late time points. Brown
dots are genes significant (FDR 5%) in both hosts. For all plots, the identity line is indicated in black. Red lines show logFC differences of5-,2-, 2- and
5-fold. r, Pearson correlation coefficients with confidence interval.
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only 18-fold upregulated at later infection times in G. mellonella.
In mice, the same gene did not vary its expression pattern during
the course of infection (approximately 350-fold upregulated com-
pared to the in vitro condition at the two time points; ALS3 is not
labeled in Fig. 3b). With regard to downregulated genes, PLB1,
encoding a phospholipase required for host cell penetration (51),
was 25-fold less expressed at 2 h than at 24 h in G. mellonella. This
gene was downregulated in mice compared to the in vitro condi-
tion, however, about 88-fold at both time points.YWP1 (encoding
a yeast wall protein) was 16-fold less expressed at early time points
than at later time points in G. mellonella. This gene followed a
similar trajectory in mice at the early time point but was further
downregulated (8-fold) at the later time point.
Very few genes were inversely regulated between early and late
time points. Namely, WOR1, ARG11, MPRL36 and orf19.5009
were upregulated at the early time point but downregulated at the
late time point in mice (Fig. 3b). HGT3, POX1-3, and orf19.2312
(CFL11) in mice (Fig. 3b), plus CWH8, LAP3, and MLH1 in
G. mellonella (Fig. 3a), were downregulated at early time points
but upregulated at late time points. In spite of the mentioned
differences between time points for some of the genes, the major-
ity of the transcriptome remained stable across time, at least at the
time points investigated here. This conclusion can also be drawn
from Fig. 3c and d, in which most of 2-fold-regulated genes
between conditions remained in the same cluster of colored data
points. A more detailed time course experiment might be needed
to observe a comprehensive kinetic of gene expression during in-
fection.
(ii) C. albicans transcriptomic signature of host infection.
The correlations betweenC. albicans expression profiles under the
different host infection conditions prompted us to identify a com-
mon gene expression signature reflecting a state of infection. A
two-step meta-analytical approach was used to identify genes af-
fected in vivo regardless of the host model and the time point
(Fig. 4a). First, z scores computed from P values were combined
meta-analytically for each host separately. Then, a unique z score
per gene was derived from the two host-specific z scores. Positive
and negative z scores reflect the fact that genes are either up- or
downregulated, respectively, in both hosts and at any time of in-
fection compared to in vitro cultures. This approach allowed the
identification of 1,169 C. albicans genes significantly affected dur-
ing the host infection process (Bonferroni P value,0.05) (Fig. 4b
and c; also, see File S2, “meta_analysis,” in the supplemental ma-
terial). Only 35 genes in mouse and 49 in G. mellonella showed a
clear host-specific response (see File S2, “Genes_Galleria_ spe-
cific” and “Genes_Mouse_specific”). Among these genes, TLO1
stands out as a gene with an inverse regulation in the two hosts.
TLO1 from a closely related species (Candida dubliniensis) was
shown to be critical for expression of genes relevant to virulence
(adhesins, iron acquisition genes, amino acid catabolic genes,
etc.), thus suggesting that TLO1 in C. albicans may have similar
functions (52). The difference of expression of TLO1 between the
two investigated hosts may suggest that this gene has a niche-
specific role.
The 1,169 genes of the host infection signature were analyzed
for their biological significance by two different approaches. First,
a gene set enrichment analysis (GSEA) was performed using a list
of regulated genes obtained from transcriptional data compiled
from the literature, including several conditions in which C. albi-
cans (i) was exposed to host cells, (ii) was grown in vitro under
conditions mimicking host environments, or (iii) was extracted
from host tissues (see File S2, “CandidaL_exp_dataL2.gmt” in the
supplemental material). The GSEA list also contains C. albicans
genes with binding sites of several transcription factors.C. albicans
genes that were classified as “in vivo-regulated” in our study were
used as a ranked list of z scores in GSEA. As shown in Fig. 5, there
were two major clusters of genes with positive (red) and negative
(green) values. The nodes within the positively regulated genes
TABLE 5 C. albicans genes most upregulated during systemic infection
orf19 name Gene name Description
Fold change compared to in vitro growth (log2 values)a
Gm, 2 h Gm, 24 h Mm, 16 h Mm, 48 h
orf19.7455 orf19.7455 Ortholog of C. dubliniensis CD36: Cd36_86630 11.38 11.24 11.80 11.60
orf19.1321 HWP1 Hyphal cell wall protein 10.46 9.89 10.63 11.54
orf19.6028 HGC1 Hypha-specific G1 cyclin-related protein involved in
regulation of morphogenesis
9.78 9.55 10.39 11.05
orf19.3374 ECE1 Hypha-specific protein 8.73 9.26 9.40 11.04
orf19.1363 orf19.1363 Putative protein of unknown function 7.85 7.38 8.53 10.45
orf19.5636 RBT5 GPI-linked cell wall protein 6.80 9.50 8.43 9.85
orf19.2060 SOD5 Cu and Zn-containing superoxide dismutase 8.55 6.97 8.43 9.59
orf19.7094 HGT12 Glucose, fructose, mannose transporter 13.09 12.62 8.41 12.76
orf19.1816 ALS3 Cell wall adhesin 8.02 4.20 8.31 8.59
orf19.5585 SAP5 Secreted aspartyl proteinase 8.22 8.57 8.25 10.22
orf19.1822 UME6 Zn(II)2Cys6 transcription factor 7.86 7.86 8.11 8.87
orf19.2457 orf19.2457 Protein of unknown function 9.59 8.99 7.91 8.41
orf19.5952 orf19.5952 Protein of unknown function 3.11 8.13 7.84 8.73
orf19.2062 SOD4 Cu and Zn-containing superoxide dismutase 7.50 9.64 7.71 6.64
orf19.2061 orf19.2061 Ortholog of C. albicans WO-1: CAWG_03846 10.23 6.52 7.56 9.61
orf19.4599 PHO89 Putative phosphate permease 6.87 7.54 7.21 7.20
orf19.1264 CFL2 Oxidoreductase; iron utilization 5.46 8.23 7.08 6.86
orf19.1930 CFL5 Ferric reductase 6.92 12.92 6.96 9.38
orf19.113 CIP1 Possible oxidoreductase 7.88 7.90 6.82 8.31
orf19.6148 orf19.6148 Homolog of nuclear distribution factor NudE,
NUDEL
4.84 6.29 6.69 8.66
a Mm, M. musculus; Gm, G. mellonella.
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cluster formed a network in which the node “BIOFILMS_UP” is
central, since it exhibits the highest number of genes connected to
other gene sets. About 300 in vivo-upregulated genes overlap
genes that are also upregulated in biofilms (1,001 genes) (53).
Consistently, the cluster of positively regulated genes contains
nodes of transcription factor binding sites (Fig. 5, green labels for
nodes BCR1, BRG1, ZAP1, and NDT80) that were reported as
important for biofilm formation (54). Other gene sets, including
genes induced by several hypha-inducing conditions, were also
present in this cluster (Fig. 5, red labels; conditions include growth
at 37°C, addition of serum, and growth in Spider medium). Hy-
phal formation is a key element of the in vivo lifestyle ofC. albicans
(55), and our transcriptional data reflect this feature. Besides these
enrichment sets, others were more related to the exposure ofC. al-
bicans to host cells or host environment (Fig. 5, orange labels;
conditions include exposure to reconstituted human epithelium,
to blood, to plasma, to macrophages, and to C. albicans from
caecum). Nodes relative to the white-opaque switch in C. albicans
are also present and suggest that genes regulated by this process
are also enriched in the in vivo gene cluster shown in Fig. 5. Fur-
thermore, this cluster also contains a gene expression set from
C. albicans infecting zebrafish, suggesting a significant overlap (52
genes over a total of 192 upregulated genes) in the response of the
fungus to infection of zebrafish, mice, and G. mellonella. In addi-
tion, the in vivo-downregulated genes of the present study were
clustered with gene sets containing mostly downregulated genes,
thus mirroring the opposite cluster. Lastly, some nodes containing
in vivo-expressed genes were identified by GSEA but were not
associated with the 2 major clusters of Fig. 5. Among them, iron-
regulated genes are present (Fig. 5, yellow labels) and also indicate
the relevance of iron homeostasis in the in vivo lifestyle of C. albi-
cans. Some nodes also indicate an inverse regulation overlapping
the group of in vivo genes. For example, genes upregulated by
hypoxia in vitro (“HYPOXIAB_UP” and “HYPOXIA20MIN_UP”)
overlap genes downregulated in vivo. While these results may sug-
gest an absence of hypoxia for C. albicans in the two hosts tested,
this inverse regulation pattern could also reflect that in vitro con-
ditions mimicking host conditions may not always reflect the
physiological status of C. albicans in vivo.
A second approach in the biological interpretation of our re-
sults was taken by subjecting in vivo genes to gene ontology (GO)
enrichment analysis. The genes were separated by their positive
and negative z scores. As shown in Table 6, positively regulated
genes were enriched for several processes, including those in-
volved in response to external stimulus, pathogenesis, biofilm/
hypha formation, and iron homeostasis. All these processes are
known to participate to the virulence of the pathogen. In addition,
many of the listed genes belong to pathways involved in cell wall
biogenesis and maintenance. Negatively regulated genes were en-
riched for processes such as cellular amino acid biosynthesis, gly-
colysis, mitochondrial electron transport, translation, and induc-
tion of host defense response. The enrichment of such processes in
this category of regulated genes reflects the fact that metabolic
functions (glycolysis and respiration), biosynthesis of cellular
FIG 4 Identification of C. albicans genes differentially expressed in vivo versus in vitro using a meta-analytical approach. (a) Meta-analysis strategy. Limma
contrast statistics were converted to z scores (see Materials and Methods). z scores were then combined meta-analytically as illustrated. (b) Scatter plot of mouse
and Galleria z scores obtained meta-analytically. Mouse and Galleria z scores are further combined into one in vivo z score. The 1,169 genes for which this
combined z score is significant (Bonferroni P value 0.05) are indicated in brown. Genes for which the combined z score is not significant are indicated in blue
if the mouse z score is significant or in green if the G. mellonella z score is significant. TLO1 is the only gene with significant and anti-correlated z scores in mouse
and G. mellonella. r, Pearson correlation coefficient with confidence interval. (c) Heat map of the 1,169 significant genes by meta-analysis. For each sample, a log
fold change versus the average in vitro expression was computed. The log fold change values were variance scaled and are represented on the heat map.
Hierarchical clustering tree of the samples is indicated at the top. Gm, G. mellonella; Mm, Mus musculus.
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components, and protein translation are less active in in vivo- than
in vitro-grown cells, which is also typical of a less favorable growth
environment.
DISCUSSION
Studies of the C. albicans transcriptome during host infections
have been hampered by the low abundance of microbial tran-
scripts within samples containing excess host RNA. In this study,
we showed that by using a hybridization-based RNA enrichment
procedure, one can target the pathogen transcriptome even when
it is diluted in a large excess of host RNA. We demonstrated that
the enrichment and amplification steps permit the quantitative
recovery of RNA from most fungal genes but not from a few that
can be identified based on a priori criteria. Essentially, insufficient
bait coverage and low GC content preclude quantitative recovery
of some of the genes through a hybridization-based procedure. A
machine-learning approach contributed to the establishment of
the relevant gene features and numerical thresholds for gene re-
jection criteria. In the future, these results could serve to guide the
design an improved set of baits. More generally, we believe that
this integration of wet-lab and in silico methods is not limited to
the particular experimental systems investigated here but is appli-
cable to a vast range of parasite/host experimental systems.
This approach allowed an unprecedented resolution of the
C. albicans transcriptome during infection. For example, in the
microarray-based in vivo study by Thewes et al. (26), only 787
C. albicans genes (strain SC5314) could be detected in mouse kid-
neys, and 476 were differentially expressed in a statistical signifi-
cant manner. In comparison, our approach allows detection of
5,365 C. albicans genes (86% of the 6,218 ORFs from C. albicans),
with 2,174 genes being differentially expressed in mouse kidneys
at 48 h p.i. (log2 fold change 2; P 0.05). The higher resolution
achieved here has the major advantage of allowing the study of
genes that might have a relevant role in infection, despite their low
expression levels. Accordingly, we identified several genes with
unknown functions that are differentially expressed in vivo. Thus,
these data may represent a milestone in the understanding ofC. al-
bicans biology.
Time-dependent gene expression. With the validated enrich-
ment procedure, we investigated the C. albicans transcriptome in
two different hosts and at two different time points. Time points
were chosen to differentiate between early and late responses of
C. albicans in the two hosts. The majority of genes were similarly
regulated at the two time points. We noticed that iron homeostasis
genes increased their expression over time in both hosts, high-
lighting the relevance of iron acquisition in the pathogenesis of
C. albicans in both hosts. SEF1 is a transcriptional activator that
positively regulates several genes mediating iron uptake under
iron-depleted conditions (56). Our data reveal that SEF1 is up-
regulated under all conditions tested here compared to in vitro
growth (7- to 9-fold in G. mellonella; 18- to 20-fold in mice) (see
File S1, “FC_mouse_16h”, “FC_mouse_48h”, “FC_Galleria_2h”,
and “FC_Galleria_24h”, in the supplemental material), consistent
with the expression profiles of SEF1 target genes discussed here,
including CFL5, RBT5, and FTR1. HAP43 and SFU1 are both
transcriptional regulators and part of the SEF1 regulatory cir-
cuit. HAP43 represses iron utilization and SFU1 represses iron
uptake systems, and these genes were up- and downregulated,
respectively, under all conditions tested here (see File S1,
“FC_mouse_16h”, “FC_mouse_48h”, “FC_Galleria_2h”, and
FIG 5 GSEA of C. albicans genes regulated in vivo. The gene list was produced from data in File S2 in the supplemental material (“meta-analysis”,
“CandidaL_exp_dataL2.gmt”), in which genes with P values of0.05 (in vivo) were chosen. The genes were ranked according to their z scores. The list was then
imported into the GSEA software. Analysis parameters were as follows: norm, meandiv; scoring_scheme, weighted; set_min, 15; nperm, 1000; set_max, 500.
GSEA results were uploaded into Cytoscape 3.0 with the following parameters: P value cutoff, 0.01; FDR q value, 0.05. Red nodes represent enriched gene lists in
upregulated genes from the GSEA. Green nodes represent enriched gene lists in downregulated genes from the GSEA. Nodes are connected by edges when
overlaps exist between nodes. The size of nodes reflects the total number of genes that are connected by edges to neighboring nodes. Edge thickness reflects the
level of confidence between nodes. Colored labels of nodes are defined in the text and indicate specific classes of genes.
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“FC_Galleria_24h”), which is in agreement with other mouse
studies (57, 58) but extends this important fungal pathogenesis
mechanism to the insect mini-host model.
Even if the global trend of regulation is similar between time
points and the two hosts, some genes were inversely regulated
between early and late stages of infection. One interesting gene
among them is WOR1, a regulator of the white-opaque switch in
C. albicans, which is upregulated at early time points but down-
regulated at late time points. The white-opaque switch, besides its
role in facilitating mating between opposite mating types, is cou-
pled with the expression of several genes involved in adhesion,
drug resistance, and metabolism (59).WOR1 expression is critical
for this switch in homozygous a or  cells; however, ectopic ex-
pression of WOR1 in a/ cells can also induce switching, though
with limited capacity. In our experiments, we observed that
WOR1 is 6-fold upregulated in mice at the early time point com-
pared to in vitro conditions but then 28-fold downregulated at the
late time point. It was recently reported that WOR1 can be ex-
pressed in a/ cells upon passage in the gastrointestinal tract (60);
however, this has not been reported yet for kidneys. WOR1 up-
regulation triggers the expression of several genes important for
C. albicans gut colonization (60) and is also involved in biofilm
formation (61). The WOR1 inverse regulation was surprising,
since most of the opaque genes are upregulated in mice at both
time points. This suggests that other morphogenesis regulators
may compensate for sustained expression of the opaque genes.
LAP3 (encoding a putative aminopeptidase) was among other
genes inversely regulated between time points in G. mellonella
(Fig. 3a). Interestingly, LAP3 is among the genes positively regu-
lated by SEF1 (56). Considering the permanent upregulation of
SEF1, this suggests that LAP3 is under the control of another,
yet-unknown regulator(s). POX1-3 (encoding acyl coenzyme A
TABLE 6 List of C. albicans genes regulated “in vivo” and categorized according to enriched GO termsa
Group and GO term
(biological process)
Enrichment
fractionc
Log odds
ratio
Adjusted
P value Gene list
Positive z scores
Regulation of response to
stimulus (GO:0048583)b
47/252 0.88 0.03 HGC1, UME6, PTP3, CEK1, orf19.6705, HGT1, SLN1, FAV1, CST5,BEM2, PRA1, KEX2,
RPN4, ALS1, orf19.2565, CLA4, orf19.3501, orf19.4792, GCN2, HSP70, RIM101,
RGS2, MSB2, IQG1, RAX1, MKK2, CCN1, SAP4, BUD2, LTE1, CAG1, GPA2, CZF1,
ZCF30, ZCF2, GEA2, SKN7, TEA1, AHR1, CPP1, TEC1, HRR25, SET1, CRZ1,
RAS1, PPR1, orf19.321
Iron ion homeostasis
(GO:0055072)
16/41 1.95 0.00 HMX1, HAP43, FTR1, IRO1, FRP1, RBT5, CSR1, CFL2, CSA2,CCC2, FET34, CSA1,
ISU1, SEF1, ALS3
Regulation of filamentous
growth (GO:1900443)
18/60 1.57 0.03 HGC1, UME6, CEK1, SLN1, CLA4, CCN1, GPA2, CZF1, ZCF30,ZCF2, SKN7, TEA1,
AHR1, CPP1, TEC1, CRZ1, RAS1, PPR1
Biofilm formation
(GO:0042710)
30/137 1.11 0.04 HWP1, RBT5, ECE1, TRY5, HYR1, HGC1, PHR1, ALS3, PGA7, CSA1, CST5, CSR1, ALS1,
TRY4, BCR1, ARG81, CSH1, SUN41, CSA2, ZNC1, TRY6,PBR1, BRG1, VPS1,
CZF1, AHR1, TEC1, IPT1, RAS1, GUP1
Pathogenesis (GO:0009405) 41/225 0.85 0.09 HWP1, PHR1, UME6, SOD5, FTR1, ALS3, FET34, CEK1, SAP5,ICL1, RBT4, HAP43,
KEX2, IFF4, ALS1, IRE1, CLA4, HEX1, CSH1, SFL2, HGT4, RIM101, IRO1, SUN41,
CHS3, BRG1, SAP4, MTLA1, CTF1, BUD2, MIT1, IRS4, SLK19, GPA2, AHR1, CPP1,
CKA2, TEC1, DUR1,2, SET1, RAS1
Biological adhesion
(GO:0022610)
21/86 1.27 0.08 HWP1, RBT5, HYR1, PHR1, ALS3, SAP5, DFI1, PRA1, IFF4,ALS1, BCR1, CSH1,
SUN41, MSB1, PBR1, SAP4, IRS4, AHR1, TEC1, SAP10, RAS1
Negative z scores
Cellular amino acid
biosynthesis (GO:0008652)
44/132 2.02 0.00 ILV3, HOM2, ARO3, ILV6, HIS1, GLO2, HIS5, LEU4, PDB1, TRP2, ANB1, THR4,
orf19.1626, HOM6, orf19.2306, PRO1, CYS4, ARO2, HOM3, HIS4, orf19.2286,
BAT21, orf19.3810, ASN1, MET16, ILV1, SER1, ARO4, MET2, TRP4, GLN1, MMD1,
THR1, ARO1, SER2, GLT1, orf19.7152, ILV5, SAM2, SER33, MIS11, GSH2, CBF1, IDP1
Glycolysis (GO:0006096) 11/16 3.07 0.00 CDC19, FBA1, GPM1, TPI1, ENO1, TDH3, PGK1, PDA1, ADH1,PFK1, PGI1
Induction of host defense
response (GO:0044416)
9/21 2.39 0.00 CDC19, FBA1, TPI1, ENO1, TDH3, PGK1, SSB1, ADH1, IMH3
Mitochondrial electron
transport (GO:0006122)
6/10 2.87 0.01 RIP1, CYT1, QCR2, QCR8, orf19.913.2, CYC1
Translation (GO:0006412) 95/404 1.52 0.00 RPP1A, RPS3, orf19.3649, orf19.5812, RPS24, RPP2A, RPS17B, RPL42, RPL2, RPL37B,
RPL39, DED81, RPP2B, ANB1, orf19.5943.1, SUI3, RPL20B, RPS19A, RPL28, RPL30,
RPS21, ARC1, RPL16A, RPS23A, RPL18, orf19.6220.4, RPL15A, RPL5, RPS1, SSZ1,
TYS1, RPS4A, RPL14, TMA19, RPL27A, RPL43A, RPS18, RPL10, orf19.5684,
SSB1, orf19.4149.1, TEF2, RPS20, DRG1, EIF4E, CAM1-1, RPL23A, RPL17B, RPL3,
orf19.3341, RPL19A, RPL13, RPL21A, RPS9B, RPS28B, GRS1, SIS1, GCD11, RPS21B,
orf19.6882.1, RPS15, RPS7A, MMD1, HCR1, RPS8A, TIF, YST1, SUP35, RPS12, GUS1,
RPL6, RPL4B, RPS6A, FRS1, RPS5, KRS1, RPS16A, RPL25, RPL9B, RPL40B, RPS22A,
CDC60, UBI3, RPL10A, orf19.3572.3, TEF1, RPL38, EFB1, THS1, RPP0, TIF34, RPP1B,
GCD6, orf19.2478.1, RPL11
a Log odds ratios and adjusted P values were obtained by performing GO term enrichment analysis with GOEAST (89). Only selected GO terms are listed.
b Corresponding GO term numbers are given in parentheses.
c Enrichment fraction was obtained by the ratio between the gene lists and the total number of genes present in a given GO term.
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oxidase enriched in stationary phase) and HGT3 (encoding a
high-affinity glucose transporter) are inversely regulated between
time points in mice (Fig. 3b) and thus reflect metabolic adaptation
upon the course of infection in this model.
Host infection transcriptomic signature. The choice of hosts
(murine and insect models) was motivated by the idea that mini-
host models such asG.mellonella could replace mammalian mod-
els in some experimental infections with C. albicans due to cost
and ethical reasons. Several laboratories have investigated fungal
virulence and antifungal drug activity with G. mellonella (62–67).
The results obtained from this insect model were consistent with
those obtained from the mouse systemic model of infection (62,
64; reviewed in reference 40) and with the pathogenicity of C. al-
bicans strains in human patients (68). The immune system of
G.mellonella can be compared with the innate immunity of mam-
mals, and the larval immune response to microorganisms can be
assessed based on antimicrobial peptide (AMP) production or
hemocyte counts (reviewed in reference 40). The infection models
used here are evolutionarily highly divergent, butC. albicans tran-
scriptomic responses in these hosts showed significant correla-
tions. A data mining approach combining time points and hosts
allowed us to delimit on one hand an in vivo-specific gene expres-
sion signature (1,169 genes), independent of the infected host,
compared to in vitro-grown cells, but on the other hand high-
lighted some highly significant host-specifically regulated genes.
Considering the 1,169 in vivo regulated genes, we performed
two types of data mining analysis, GO term analysis and GSEA.
Interestingly, GO term analysis highlighted genes in the category
“induction of host defense response,” including CDC19, FBA1,
TPI1, ENO1, TDH3, PGK1, SSB1, ADH1, and IMH3. The prod-
ucts of these genes are antigenic in animal models (69–71), and
therefore, their downregulation in vivo can be taken as a fungal
strategy to diminish adaptive host defenses. GSEA showed that the
set of 1,169 in vivo specific genes extensively overlapped previ-
ously published genome-wide transcriptional analysis of C. albi-
cans exposed to in vitro conditions mimicking the host environ-
ment. Moreover, the set of in vivo-regulated genes also overlapped
data sets originating from transcriptional analysis from host sam-
ples, including zebrafish, mouse, and human samples. The con-
served expression profile of C. albicans found here for mice and
G. mellonella suggests that the pathogenesis mechanisms of C. al-
bicans may be similar in both hosts. On the other hand, since
C. albicans is, as far as the literature reports, not a natural pathogen
of insects, the mammal-specific host response of C. albicans may
be fortuitously sufficient for pathogenesis in G. mellonella. In any
case, absence of important virulence factors in C. albicans may
result in similar disease outcomes in both hosts. As mentioned
earlier, several studies have concluded that the response of mice to
specific C. albicans mutants can be phenocopied in G. mellonella
infections. Our transcriptional data showed for the first time at the
transcriptional level this convergence between the two animal
models.
However, our data also highlight a few host-specific character-
istics of the C. albicans transcriptional response. Among mouse-
specific and upregulated genes are MNN4-4 (encoding a manno-
syltransferase) and DAG7 (encoding a secreted protein; both are
downregulated in mice but upregulated in G. mellonella). While
the putative function of DAG7 is unknown, it contains a barwin-
like endoglucanase domain (IPR014733). MNN4-4 and DAG7
may therefore modify cell wall composition in C. albicans accord-
ing to the specific host environment. In addition,TLO1 stands out
as a gene with an inverse regulation in G. mellonella. TLO1 is
known as a member of the telomere-proximal genes with homol-
ogy to the Med2 subunit of Mediator (72). TLO1 from a closely
related species (C. dubliniensis) was shown to be critical for ex-
pression of genes relevant to virulence (adhesins, iron acquisition
genes, amino acid catabolic genes, etc.), thus suggesting thatTLO1
in C. albicans may have similar functions (52). The difference of
expression of TLO1 between the two hosts investigated may sug-
gest that this gene has a niche-specific role. Accordingly, the list of
Galleria-specific genes contains several TLO genes (CTA24/
TLO12, CTA2/TLO3, and TLO1). The downregulation of these
other TLO genes in G. mellonella may reflect a specialized role for
TLO family members. From the list of Galleria-specific genes, we
noticed that several cell wall-associated genes (PGA57, PGA50,
and PGA1), genes encoding amino acid and amine transporters
(GAP2 and TPO5), and genes encoding 3 different cyclins (PCL1,
PCL2, and CLN3) were upregulated. While differential regulation
of cell wall genes may be associated with cell wall modifications,
the specific regulation of transporters may be understood as alter-
ations in nutrient acquisition. The regulation of both PCL1 (en-
coding a cyclin that was shown to be critical for hypha formation
at high temperature or HSP90 inhibition) and CLN3 (encoding a
cyclin required for yeast and hyphal growth) suggests a more dy-
namic morphogenesis in G. mellonella than in mice at the time
points investigated (73, 74). Among downregulated Galleria-
specific genes, several genes involved in the control of gene expres-
sion are present, including TYE7 (a bHLH [basic Helix-Loop-
Helix] transcription factor controlling glycolysis) (75). Consistent
with this observation, several glycolytic genes, such as PDX1 (en-
coding pyruvate dehydrogenase complex protein), PYC2 (encod-
ing pyruvate carboxylase), SHA3 (encoding a Ser/Thr kinase in-
volved in glucose transport), OSM1 (encoding a flavoprotein
subunit of fumarate reductase) and HXK2 (encoding hexokinase
II), are also Galleria-specific downregulated genes.
Finally, we compared our results with a recent study by Xu et al.
(24) in which the expression of a small set of genes (248) was
measured from kidney lysates taken at early (12 h) and late (48 h)
infection time points. We could match a total of 85 genes between
the two studies, thus including 49% of the regulated genes identi-
fied in the work of Xu et al. (24). As shown in Fig. 6, early gene
expression patterns were highly concordant between both studies
(r  0.89). Given that time points designated “early” differ be-
tween the two studies (12 h versus 16 h), these correlation coeffi-
cients highlight a good agreement. This observation further
strengthens the validation of the method chosen here for RNA
enrichment.
Dual RNA-seq of host and pathogen. Dual RNA-seq of host
and pathogen during infection would be optimal for maximizing
the utility of transcriptomics studies. However, as mentioned ear-
lier, this is often limited by the low proportions of pathogen in the
host tissues. Two recent studies have attempted dual RNA-seq
withC. albicans-infected host samples. For example, Liu et al. (38)
sequenced the transcriptomes of infected mouse kidneys but
could draw conclusions only on the host side. Bruno et al. (39)
studied a murine vulvovaginal candidiasis (VVC) model, but the
reads mapped to C. albicans constituted less than 0.1% of the
samples. As a result, the authors could not conduct a genome-
wide analysis of C. albicans but could analyze only 52 genes. On
the other hand, both of these studies were highly successful in
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analyzing the host response to the pathogen. In the present work,
we were able to comprehensively examine the transcriptional pro-
file of the pathogen after applying the enrichment procedure. En-
riched samples still contained 10 to 50% host sequences. However,
we observed a nonnegligible bias for the mouse transcriptome
when comparing enriched and nonenriched samples (data not
shown). We concluded that enriched RNA-seq libraries can be
used only to analyze the pathogen response but that the same RNA
extracts can be used to prepare nonenriched libraries and there-
fore to study both pathogen and host in any context of infection.
This will allow the dissection of the host-pathogen cross talk at a
transcriptional level in more detail.
Conclusions. The RNA enrichment technology used here was
first designed to target the human exome and is now widely used
for this purpose. The enrichment technology used here has, to our
knowledge, not been used until now to enrich for microbial RNA
from host tissues. In principle, the method could be implemented
in other types of microbial systems in which the microbial RNA is
found in small amounts in host samples. With regard to C. albi-
cans biology, this method can be used to analyze its kinetic of
infection at a transcriptional level in other organs besides kidneys.
On the other hand, the enrichment procedure may help the en-
richment of RNA from mutants with virulence and/or coloniza-
tion defects in specific hosts. In the future, we aim to enrich for
RNA of C. albicans mutants with decreased virulence, and even if
fungal RNA is even further diluted by host RNA, the analysis of
mutant transcriptomes may be still be possible. These experi-
ments are currently undertaken in our laboratory. Moreover, fun-
gal RNA enrichments can be envisaged on human biopsy samples.
This would indeed contribute to the analysis of fungal transcrip-
tional response directly in the context of human infection, since
our understanding is now limited to experimental systems that
only partially reflect human disease.
MATERIALS AND METHODS
Mouse infections andorgan collection.All animal experiments were per-
formed at the University of Lausanne and at the University Hospital Cen-
tre under the surveillance and with the approval of the institutional Ani-
mal Use Committee, Affaires Vétérinaires du Canton de Vaud,
Switzerland, authorization no. 1734.3, according to decree 18 of the fed-
eral law on animal protection. Infection of 6-week-old BALB/c mice (Mus
musculus) was performed as described previously (62). Part of the in vitro
cell culture used for infection was saved for RNA extraction, constituting
the in vitro samples used for the RNA-seq analysis. Six to eight mice were
injected through the tail vein with 250l of cell suspension, and two mice
were injected with phosphate-buffered saline (PBS; 137 mM NaCl,
2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4) (mock infection) in
each experiment. At 16 h and 48 h postinfection (p.i.), 3 or 4 infected mice
and one mock-infected mouse were randomly chosen (no blinding) and
sacrificed (see Fig. S1 in the supplemental material). Kidneys were col-
lected, immediately halved, and placed in vials containing 1 ml of
RNAlater solution (Life Technologies). This reagent immediately stabi-
lizes RNA in tissue samples to preserve the gene expression profile. Sam-
ples were kept on ice and then at80°C until the time of RNA extraction.
This experiment was performed twice. The number of animals used was
chosen so that each sample represented an average of 3 animals, to reduce
interindividual noise.
G. mellonella infections. As previously described (62), G. mellonella
larvae were purchased from Bait Express GmbH (Basel, Switzerland).
Upon arrival, the larvae were stored at 12°C in the dark with wood shav-
ings, and larvae were used within a maximum of 2 weeks. Larvae weighing
300 to 400 mg were used for the experiments. C. albicans SC5314 strain
was grown overnight under agitation at 30°C in yeast extract-peptone-
dextrose (YEPD), then diluted 100-fold in YEPD, and grown to an ap-
proximate density of 1.5  107 cells/ml (measured by optical density).
Cultures were then washed twice in PBS and resuspended in 5 ml PBS. The
concentration of the culture was measured by optical density, and the
culture diluted in PBS to 1.25 107 cells/ml. Part of the in vitro cell culture
was saved for RNA extraction, constituting the in vitro samples used for
the RNA-seq analysis. Six to eight larvae were injected through the last left
proleg, using a Myjector U-100 insulin syringe (Terumo, Europe), with
40 l of cell suspension, and two larvae were injected with PBS (mock
infection). Larvae were kept at 30°C in the dark. At 2 h and 24 h p.i., 3 or
4 infected larvae and one mock-infected larva were randomly chosen (no
blinding), sacrificed (see Fig. S1 in the supplemental material), and directly
used for RNA extraction. This experiment was performed twice. The number
of animals used was chosen so that each sample represented an average of 3
animals, to reduce interindividual noise.
RNA extraction.When cell suspensions were prepared for infection
of mice or larvae, 50 ml of the 1.5  107cell/ml suspensions was kept
for direct RNA extraction of the in vitro culture. RNA was extracted
from in vitro cultures, mouse kidneys, and G. mellonella larvae as pre-
viously described (62). The list of RNA extracts and the corresponding
conditions are listed in Table S2 in the supplemental material. After
analysis of RNA quality (see below), the 3 or 4 RNA samples from the
same animal species and same time point were combined and further
analyzed as a single sample (see Table S2 in the supplemental mate-
rial). Therefore, each final RNA sample constituted an average of 3 or
4 biological replicates (see Fig. S1 in the supplemental material). This
was done in duplicate.
Analysis of RNA integrity. RNA quality was analyzed in a 2100 Bio-
analyzer system (Agilent Technologies) according to manufacturer’s in-
structions. RNA was denatured at 70°C for 2 min prior to analysis. Since it
was not always possible to calculate an RNA integrity value (RIN), sam-
ples were included in the study according to visual examination of the
Bioanalyzer profiles (two clear peaks for 18S and 25/28 S for C. albicans
and mouse samples and one clear peak at 18S for G. mellonella samples,
with no obvious degradation).
qPCR quantification of C. albicans transcripts. (i) Estimation of
proportion of fungal RNA in the total in vivo-extracted RNA samples
infected with different inocula and at different time points. Reverse
transcriptase reactions were carried out as previously described (62). This
FIG 6 Correlations between log2 fold change (logFC) data generated in this
study and from reference 24, taking early gene expression patterns from both
studies (Xu et al. [24], mouse kidneys 12 h p.i. versus in vitro stationary-phase
culture; Amorim-Vaz et al. [62], mouse kidneys 16 h p.i. versus in vitro
exponential-phase culture). r, Pearson correlation coefficient, calculated with
Prism 6.0.
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cDNA was used to determine the percentage of C. albicans transcripts in
each sample by real-time quantitative PCR (qPCR) targeting ACT1 of
C. albicans using primers ACT1-RT-F and ACT1-RT-R and a TaqMan
probe ACT1-RT-P (see Table S3 in the supplemental material for details
on the primers and probe used). Quantitative PCR was performed in a
StepOnePlus real-time PCR system (Applied Biosystems) instrument.
Different concentrations of in vitro-extractedC. albicans cDNA were used
in each qPCR to establish a calibration curve, which was then used to
calculate the percentage of fungal RNA in the in vivo-extracted RNA sam-
ples.
(ii) Validation of RNA sequencing data. To validate RNA-seq data,
expression levels of 8 genes (DAG7, HWP1, TLO1, TRY5, UPC2, YWP1,
ZRT1, and orf19.7455) were determined by qPCR. One microgram (de-
termined with a NanoDrop 1000 spectrophotometer; Thermo, Fisher Sci-
entific) of the RNA used for RNA-seq was reverse transcribed using ran-
dom hexamers as a priming method (Transcriptor high-fidelity cDNA
synthesis kit; Roche). Subsequent qPCRs were performed with a 0.2 M
concentration of each primer and a 0.2 M concentration of probe for
ACT1,DAG7,HWP1, TLO1,UPC2, and ZRT1 or a 0.4M concentration
of each primer and a 0.1 M concentration of probe for TRY5 and YWP1
and iTAQ Supermix with ROX (Amine-reactive carboxy-x-rhodamine)
(BioRad, Reinach, Switzerland) according to the manufacturer’s instruc-
tions. Sequences of primers and probes are shown in Table S3 in the
supplemental material. Three standard curves were calculated for each
gene: one using cDNA from in vitro-grown C. albicans (used to calculate
gene expression levels of in vitro C. albicans samples), one using cDNA
from noninfected mice spiked with 1% of cDNA from in vitro-grown
C. albicans (used to calculate gene expression levels in samples from in-
fected mice), and one using cDNA from noninfected G. mellonella spiked
with 1% of cDNA from in vitro-grown C. albicans (used to calculate gene
expression levels in samples from infected larvae). The expression level of
ACT1 was used for normalization. All reactions were repeated twice.
Initial probe design. Nonoverlapping head-to-tail 120-nucleotide
probes were designed using the eArray software (Agilent Technologies,
Santa Clara, CA). A total of 55,342 bait probes were designed to cover
6,094 C. albicans ORFs (assembly 21 SC5314; 16-Mb haploid genome;
6,218 ORFs). The first 250 nucleotides of each gene were not covered in
the bait design, resulting in an average of 9 probes for each ORF. Using
Megablast (v2.2.26) (76), it was verified that all genes of C. albicans were
matched by at least one probe and that only a negligible fraction of the
probes could be mapped on the mouse and human cDNA sequences from
Ensembl and on the available G. mellonella expressed sequence tags
(ESTs) and cDNA sequences from NCBI.
Feature selection and gene classification.We used Perl and R to com-
pute the numeric gene features and carry out the analysis. The Dustmas-
ker module from NCBI-BLAST (v2.2.29) (77) was used to acquire the
low-complexity regions. RNALfold (v2.1.8) (78) was applied to calculate
the folding free energy. The Megablast module from BLAST (v2.2.26) (76)
was used to align the probes against themselves and to form clusters of
similar probes, and the number of sequences clustered together was taken
as a measure of redundancy.
For the feature selection process, we investigated five different search
methods, with the correlation-based feature subset evaluator, proposed
by the WEKA workbench (v3.6.11) (79): best first, greedy stepwise, linear
forward selection, scatter search, and subset size forward selection. We
then built a linear weighted support vector machine model (43) with the
Kernlab R package (v0.9.19) (80) to assess the importance of the selected
features and to classify the genes accordingly.
Preparation of RNA-seq libraries. RNA libraries for RNA-seq were
prepared using the SureSelectXT multiplexed sequencing kit with RNA
target enrichment for Illumina or the SureSelect multiplexed sequencing
kit with strand-specific RNA library preparation for Illumina (Agilent
Technologies), for enriched and nonenriched samples, respectively, ac-
cording to the manufacturer’s instructions. Briefly, mRNA was purified
by poly(A) capture and enzymatically fragmented. Next, double-stranded
cDNA was produced with adapters ligated to both ends. The library was
then amplified using provided primers which hybridize to the previously
inserted adapters, therefore allowing a linear amplification of all tran-
scripts present in the sample. In the case of nonenriched libraries, RNA-
seq indexes were also inserted during this PCR. Each library received a
different index (see Table S2 in the supplemental material). This index
allows several libraries to be sequenced together (multiplexing), and the
index sequence was used to distinguish between samples. For enriched
libraries, double-stranded cDNA ligated to adapters was also amplified by
PCR according to the manufacturer’s instructions and was then incubated
at 65°C for 24 h with a set of biotinylated oligonucleotides specifically
designed to captureC. albicans transcripts (baits), as described above. The
hybridized sequences were captured with magnetic streptavidin beads.
They were next linearly amplified using provided primers and indexed in
a new PCR.
For analysis of in vitro samples, RNA from noninfected mouse or
G. mellonella was spiked with 1% of in vitro C. albicans RNA samples.
Then, these spiked in vitro samples were subjected to the same enrichment
procedure as in vivo samples.
No batch effect was observed between libraries prepared in different
days (see Fig. S4 in the supplemental material).
Before sequencing, libraries were analyzed with a fragment analyzer
automated CE system (Advanced Analytical) to assess quality and frag-
ment size and with a Qubit fluorometer (Invitrogen) to determine cDNA
concentration. Libraries were kept at20°C until they were sequenced.
RNA sequencing. Cluster generation was performed with the result-
ing libraries using the Illumina TruSeq PE cluster kit v3 reagents and
sequenced on the Illumina HiSeq 2500 system using TruSeq SBS kit v3
reagents. Sequencing data were processed using Illumina Pipeline soft-
ware version 1.82. Purity-filtered reads were adapters- and quality-
trimmed with Cutadapt (v1.2.1) (81) and filtered for low complexity with
Prinseq (v0.20.3) (82). Reads were aligned against Candida albicans ge-
nome SC5314 version A21-s02-m09-r07 using TopHat2 (v2.0.9) (83).
The number of read counts per gene locus was summarized with htseq-
count (v0.5.4p3) (84).
Data normalization and differential expression analysis were per-
formed in R (v3.1.1), using Bioconductor packages. The read count data
were normalized with the TMM (trimmed mean of M-values) method
available in the R Bioconductor package edgeR (85) and subsequently
transformed to log2 counts per million by Voom, a method implemented
in the R bioconductor package Limma (86). A linear model with one
factor per condition was applied to the transformed data using Limma
(87) (see File S1, “normalized_gene_expression” in the supplemental ma-
terial). The conditions were the following: in vitro, 2 h p.i. inG.mellonella,
24 h p.i. in G. mellonella, 16 h p.i. in M.musculus, 48 h p.i. in M.musculus
(all in duplicate). Four contrasts, representing the difference between in
vivo conditions and in vitro conditions, were extracted from the linear
model, resulting in a moderated t statistic for every gene in every in vivo
condition.
A two-step meta-analytical approach was used to identify genes af-
fected in vivo regardless of the host model and the time point (see the R
scripts in File S3 in the supplemental material). First, as described by
Wirapati et al. (88), the P values for the two time points of a host were
converted to z scores taking into account the sign of the t statistic and
combined meta-analytically into one z score per host. Then, the resulting
G. mellonella and M. musculus z scores were again combined meta-
analytically into one global z score reflecting the chance that a particular
gene is affected in vivo. P values calculated from the meta-analysis were
adjusted using Bonferroni corrections, and adjusted P values of 0.05
were considered significant.
Sequence data accession number. RNA-seq raw data reported here
are accessible under the BioProject accession number SRP058281.
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